Abiopharma

🔍 Butler John P. (Executive)

Company: Akebia Therapeutics, Inc. (AKBA)

Report Date: 2026-08-06

Detailed Transactions and Holdings:

• Acquired 350,000 shares of Common Stock at $0.63 per share (Direct)
  Date: 2026-08-06 | Code: M | equity_swap_involved: false | shares_owned_after: 3,718,564.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-06 | Code: H | nature_of_ownership: Held by Dorothy Butler Revocable Trust November 20, 2007 | shares_owned_after: 159,928.00
• Sold 350,000 shares of Stock Option (Right to buy) at $0.63 per share (Derivative)
  Date: 2026-08-06 | Code: M | Expires: 2033-01-31 | equity_swap_involved: false | shares_owned_after: 525,000.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Includes 1,500 shares of the Issuer's common stock purchased on June 30, 2026 under the Issuer's Amended and Restated 2014 Employee Stock Purchase Plan.
• F2: The options were granted by the Issuer on January 31, 2023 and vest over four years: 25% of the options vested on January 31, 2024 with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.